glp 1 and basal insulin GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Fixed-ratio combination of GLP-1 receptor

VacaGArmbulaEMonsalvoAMedinaCNuezCSandovalLet alGlucose-6-phosphate dehydrogenase (G-6-PD) mutations in Mexico: four new G-6-PD variants

243 The prevalence of SIBO in IBS varies across studies, but estimates range from about 2084%

Livagen treatment increased the average number of SCEs per cell across nearly all chromosome groups, with the exception of group F composed of chromosomes 19 and 20, where the effect was insignificant

Soluble fiber slows glucose absorption, preventing the rapid swings that can trigger nausea in GLP-1 users, especially between meals

Hirrlinger J1, Gutterer JM, Kussmaul L, Hamprecht B, Dringen R

Severe Hypokalemia: A Critical Drop in Potassium Levels One of the most serious complications of B12 replacement therapy in severe megaloblastic anemia (a type of anemia where blood cells are abnormally large) is the development of severe hypokalemia (dangerously low potassium levels in the blood)